Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pal Miheller

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Gastroenterology & Hepatology|December 17, 2008
International Falk Foundation 164th Falk SymposiumPal Miheller
Expert Opinion on Drug Metabolism & Toxicology|October 6, 2010
Thiopurines in Crohn's disease, is there something new?Pal Miheller, Peter Laszlo Lakatos
Digestive Diseases (Basel, Switzerland)|September 11, 2007
Carcinogenesis in inflammatory bowel diseaseLaszlo Herszenyi, Pal Miheller, Zsolt Tulassay
World Journal of Gastroenterology|November 25, 2010
Clinical relevance of changes in bone metabolism in inflammatory bowel diseasePal Miheller, Katalin Lorinczy, Peter-Laszlo Lakatos
Annals of Gastroenterology|April 10, 2014
Manipulating bone disease in inflammatory bowel disease patientsPal Miheller, William Gesztes, Peter L Lakatos
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Nutritional influences in selected gastrointestinal diseasesPeter Laszlo Lakatos, Lajos S Kiss, Pal Miheller
Current Drug Targets|May 9, 2013
Methotrexate: should we start using it in clinical practice?Pal Miheller, Lajos S Kiss, Michael Mandel, et al.
Expert Opinion on Biological Therapy|December 14, 2011
Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?Pal Miheller, Lajos Sandor Kiss, Katalin Lorinczy, et al.
Expert Review of Clinical Immunology|September 28, 2013
Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?Pal Miheller, Michael D Mandel, Katalin Mullner, et al.
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Infliximab therapy improves the bone metabolism in fistulizing Crohn's diseasePal Miheller, Gyorgyi Muzes, Tamas Zagoni, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Gastroenterology & Hepatology|December 17, 2008
International Falk Foundation 164th Falk SymposiumPal Miheller
Expert Opinion on Drug Metabolism & Toxicology|October 6, 2010
Thiopurines in Crohn's disease, is there something new?Pal Miheller, Peter Laszlo Lakatos
Digestive Diseases (Basel, Switzerland)|September 11, 2007
Carcinogenesis in inflammatory bowel diseaseLaszlo Herszenyi, Pal Miheller, Zsolt Tulassay
World Journal of Gastroenterology|November 25, 2010
Clinical relevance of changes in bone metabolism in inflammatory bowel diseasePal Miheller, Katalin Lorinczy, Peter-Laszlo Lakatos
Annals of Gastroenterology|April 10, 2014
Manipulating bone disease in inflammatory bowel disease patientsPal Miheller, William Gesztes, Peter L Lakatos
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Nutritional influences in selected gastrointestinal diseasesPeter Laszlo Lakatos, Lajos S Kiss, Pal Miheller
Current Drug Targets|May 9, 2013
Methotrexate: should we start using it in clinical practice?Pal Miheller, Lajos S Kiss, Michael Mandel, et al.
Expert Opinion on Biological Therapy|December 14, 2011
Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?Pal Miheller, Lajos Sandor Kiss, Katalin Lorinczy, et al.
Expert Review of Clinical Immunology|September 28, 2013
Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?Pal Miheller, Michael D Mandel, Katalin Mullner, et al.
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Infliximab therapy improves the bone metabolism in fistulizing Crohn's diseasePal Miheller, Gyorgyi Muzes, Tamas Zagoni, et al.
Pageof 3